Regulation Neutral 5

FDA's Flavored Vape OK Under Legal Fire: 5.2% of Teens Vape

· 4 min read · Verified by 8 sources ·
Share

Key Takeaways

  • The 2025 National Youth Tobacco Survey reports a record low but persistent 5.2% youth e-cig use, intensifying American Lung Association demands for FDA to reverse its flavored vape authorizations.
  • This regulatory reversal could spawn new administrative law challenges and test the scope of FDA’s tobacco authority, especially given the nearly 90% flavor preference among underage users.
  • Legal experts weigh the viability of forced authorization revocations against public health considerations.

Mentioned

U.S. Food and Drug Administration organization FDA American Lung Association organization Thomas Carr person National Youth Tobacco Survey survey flavored vapes product e-cigarettes product nicotine pouches product

Key Intelligence

Key Facts

  1. 1Overall youth tobacco use fell to 7.2% in 2025, a 36% decline from 11.3% in 2022, representing approximately 2 million middle and high school students.
  2. 2E-cigarette use dropped to 5.2% from 9.4% over the same period, yet remains the most popular product—89.4% of teen vapers choose flavored options.
  3. 3Nicotine pouches rank second at 1.7%, surpassing cigarettes (1.4%) for the second consecutive year, followed by cigars (1.1%), smokeless tobacco (0.9%), and heated tobacco (0.7%).
  4. 4The American Lung Association is formally urging the FDA to reverse its authorizations of flavored vaping products, asserting flavors are the primary driver of youth initiation.
  5. 5Thomas Carr, ALA national policy director, emphasized that tobacco is the leading cause of preventable death, with addiction almost always starting in the teenage years.

Analysis

FDA's Case
  • Authorized flavored vapes for adults may help smokers quit, reducing overall harm
  • Youth e-cigarette use has dropped 45% since 2022 despite some flavored product availability
Public Health Advocates' Case
  • 89.4% of youth vapers choose flavors, showing strong youth appeal
  • Flavored products serve as a gateway, with most adult smokers starting as teens

Analysis

For regulatory attorneys and compliance officers, the FDA’s authorization of flavored vaping products is under a spotlight that could reshape the legality of youth-appealing nicotine products. With the American Lung Association publicly demanding a reversal, the agency faces potential administrative reviews and litigation that could set binding precedents on how health agencies weigh harm reduction against youth protection.

The U.S. Food and Drug Administration’s 2025 National Youth Tobacco Survey (NYTS) marks a historic low in teen tobacco use, with just 7.2% of middle and high school students reporting current use of any tobacco product, down from 11.3% in 2022. Despite this progress, nearly 2 million adolescents still consume nicotine, and e-cigarettes remain the dominant driver—5.2% of youth vape, a steep drop from 9.4% three years earlier but still the most prevalent product. The American Lung Association (ALA) immediately seized on the data to demand the FDA reverse its authorizations of flavored vaping products, pointing to the statistic that nearly 90% of young vapers choose flavored options, overwhelmingly fruit flavors. Thomas Carr, the ALA’s director of nationwide policy, framed tobacco as “the No. 1 cause of preventable death in the country,” noting that addiction almost always begins in adolescence.

Food and Drug Administration’s 2025 National Youth Tobacco Survey (NYTS) marks a historic low in teen tobacco use, with just 7.2% of middle and high school students reporting current use of any tobacco product, down from 11.3% in 2022.

The regulatory tension at the heart of this story is the FDA’s dual mandate under the 2009 Family Smoking Prevention and Tobacco Control Act: protect public health while still allowing adult smokers access to potentially less harmful alternatives. For years, the agency walked a tightrope—denying millions of flavored e-cigarette marketing applications, then beginning to authorize certain products, including menthol and other non-tobacco flavors, for manufacturers like NJOY under the premarket tobacco product application (PMTA) pathway. The ALA and other public health groups contend that any flavored product, even those aimed at adult conversion, inevitably attracts underage users. The 2025 survey offers ammunition for both sides. Youth vaping has declined by 45% since 2022, suggesting that overall declines can coexist with some flavored product availability. Yet with 89.4% of youth vapers favoring flavors, the appeal to adolescents is undeniable.

The survey also highlights a shifting product landscape: nicotine pouches (1.7%) now surpass cigarettes (1.4%) as the second most common tobacco product among teens, a trend that has emerged amid rising popularity of brands like Zyn. Cigars, smokeless tobacco, and heated tobacco products all registered at or below 1.1%, underscoring e-cigarettes’ outsized role. For public health, the persistence of 2 million youth users means that a new generation remains at risk for lifelong nicotine addiction, respiratory issues, and dual use with combustible cigarettes. The FDA itself has acknowledged that most adult smokers start before age 18, so preventing initiation is critical to long-term disease prevention.

What to Watch

The ALA’s call to reverse flavored vape authorizations is both a policy proposal and a potential legal trigger. Should the FDA refuse, advocacy groups may sue under the Administrative Procedure Act, arguing that authorizing products with known youth appeal violates the “appropriate for the protection of public health” standard. Conversely, if the FDA bows to pressure and rescinds authorizations, manufacturers could challenge the reversal as arbitrary and capricious, citing reliance interests and the agency’s prior findings. This legal volatility injects uncertainty into the vaping market and could affect pending PMTA applications for other flavored products.

Looking ahead, the 2026 midterm elections and ongoing leadership changes at the FDA will shape the pace and direction of enforcement. Congressional pressure on the flavor issue is likely to increase, especially if youth vaping numbers plateau rather than continue to fall. Meanwhile, state and local flavor bans continue to proliferate, creating a patchwork regulatory environment that compounds compliance challenges. The central question remains: can the FDA craft a regulatory framework that both supports adult smoking cessation and prevents a flavored-product pipeline to teen addiction? The 2025 NYTS suggests the agency has made progress but is far from a solution, and the ALA’s urgent warning ensures the debate will intensify in the months ahead.

Sources

Sources

Based on 8 source articles

How we covered this story

Every story in our legal coverage is assembled from multiple primary sources, cross-referenced for factual consistency, and scored along three independent dimensions: sentiment, operational impact, and source-cluster confidence. Single-source rumors and unverifiable claims do not pass our editorial gate. When a story shows "Verified by N sources" with N≥2, the development is independently corroborated; when N=1, we mark it explicitly so readers can weigh the signal accordingly.

Impact scoring uses a 1-10 scale weighted toward regulatory, financial, and operational consequence rather than coverage volume. A topic that runs in every outlet but moves no real decisions ranks lower than a niche regulatory filing that reshapes how operators in the legal space have to behave. Read our full methodology for the scoring rubric, our glossary for term definitions, and our trends index for the longitudinal view across the beat.